2023
DOI: 10.1016/j.jvc.2023.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Use of physical examination, electrocardiography, radiography, and biomarkers to predict echocardiographic stage B2 myxomatous mitral valve disease in preclinical Cavalier King Charles Spaniels

S. Wesselowski,
S.G. Gordon,
R. Fries
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 34 publications
1
0
0
Order By: Relevance
“…A VLAS cutoff > 2.5 best identified MVD dogs with cardiac enlargement, which is in agreement with previously published results [6,7,14,30]. However, other authors have reported lower cutoffs, >2.2 [23], >2.3 [30][31][32][33], and >2.4 [8,15,18]. Considering the M-VLAS, a cutoff > 3.6 showed the optimal clinical utility, a result in line with the literature [15].…”
Section: Discussionsupporting
confidence: 91%
“…A VLAS cutoff > 2.5 best identified MVD dogs with cardiac enlargement, which is in agreement with previously published results [6,7,14,30]. However, other authors have reported lower cutoffs, >2.2 [23], >2.3 [30][31][32][33], and >2.4 [8,15,18]. Considering the M-VLAS, a cutoff > 3.6 showed the optimal clinical utility, a result in line with the literature [15].…”
Section: Discussionsupporting
confidence: 91%